2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow XC221: new trials by email Literature Review of XC221 trials Research Report on XC221
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Effect of Food Intake on the Bioavailability of XC221 100 mg Tablets XC221 100 mg tablets - Healthy | Phase 1 | Completed | Valenta Pharm JSC | 24 | 2022-02-10 | 2023-07-27 |
| Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers XC221 60 mg, XC221 200 mg, Placebo - Influenza, Acute Respiratory Infection | Phase 1 | Completed | PHARMENTERPRISES LLC | 32 | 2017-05-22 | 2018-03-08 |
Influenza, Human (1)
PHARMENTERPRISES LLC (1) · Valenta Pharm JSC (1)
Russia (2)